Novan Provides SB206 Program and Business Update
06 févr. 2020 08h30 HE
|
Novan, Inc.
FDA grants Type C meeting for SB206 to be held on April 1, 2020Last subject completes last visit, Week 24 safety evaluationAdditional 12-week efficacy and safety data provided MORRISVILLE, N.C., Feb....
Novan Reports Top-Line Efficacy Results from Phase 3 Trials of SB206 for Molluscum Contagiosum
02 janv. 2020 16h15 HE
|
Novan, Inc.
Company to hold conference call Friday, January 3, 2020 at 8:30 am Eastern TimeFocus of call: top-line efficacy data and sensitivity analyses MORRISVILLE, N.C., Jan. 02, 2020 (GLOBE NEWSWIRE) --...
Novan Announces Planned Chief Executive Officer Transition
18 déc. 2019 08h00 HE
|
Novan, Inc.
Paula Brown Stafford appointed as CEO effective February 2, 2020G. Kelly Martin’s term as CEO will end on February 1, 2020, per his employment contractMr. Martin will step down from the Novan Board of...
Novan Further Expands its Proprietary Nitric Oxide Platform
18 oct. 2019 08h30 HE
|
Novan, Inc.
A new product candidate, SB207, to target anti-viral opportunitiesPre-IND meeting anticipated in December 2019Development of SB207 to be focused on indications with unmet patient need, such as...
Novan’s Phase 2 SB206 Molluscum Study Published in Journal of the American Academy of Dermatology
08 oct. 2019 08h30 HE
|
Novan, Inc.
MORRISVILLE, N.C., Oct. 08, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company’s Phase 2 molluscum study, designed to evaluate topical...
Novan Awarded Approximately $1.1 Million Grant by Department of Defense
20 sept. 2019 08h30 HE
|
Novan, Inc.
Funds to progress women’s health product candidate, WH504Additive to recently announced NIH grant for WH602Women’s health initiative to focus on potential HPV related onco-virus therapeutics ...
Novan Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
11 sept. 2019 16h05 HE
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Compensation Committee of Novan’s Board of Directors granted stock...
Novan and Aspire Capital Enter into a Common Stock Purchase Agreement for up to $25 Million
05 sept. 2019 06h30 HE
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 05, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (Nasdaq:NOVN) today announced that the Company has entered into a Common Stock Purchase Agreement (the...
Novan Hires Michelle Patterson as Vice President of Project Management
03 sept. 2019 16h05 HE
|
Novan, Inc.
Underscores Company’s preparation for potential NDA submission for SB206 in molluscumRole to lead cross-functional coordination of key activities and timelines for the programSB206 top line results...
Novan to Participate in H.C. Wainwright 21st Annual Global Investment Conference
03 sept. 2019 09h00 HE
|
Novan, Inc.
MORRISVILLE, N.C., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ:NOVN) today announced that it will participate in the H.C. Wainwright 21st Annual Global...